| |
|
|
|
Soleno Therapeutics Inc.  
|
|
4 -0.23 (-0.05%) |
05-22 16:00 |
|
Open: |
4.27 |
Pre close: |
4.23 |
Target:
|
5.13
|
|
High: |
4.36 |
Low: |
3.88 |
Resistance:
|
4.39
5.13
|
|
Volume: |
250,993 |
Market Cap: |
179M |
Support:
|
3.33
2.67
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.91
 |
MACD |
MACD(12,26):
|
0.29 |
|
MA(20): |
3.41 |
Signal(12,26,9): |
0.23 |
|
MA(100): |
2.94 |
Stochastic Oscillator |
%K(14,3):
|
82.86  |
|
MA(250): |
2.40 |
%D(3): |
82.18 |
|
Average Volume(K) |
3-Month: |
14655
|
52-Week |
High:
|
4.39 |
|
10-Days: |
23019 |
Low: |
1.18 |
|
RSI |
RSI(14):
|
67.30 |
Change(%): |
68.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.792 |
Return on Equity (ttm) |
-178.8 |
Shares Out. (M) |
44.71 |
|
EPS Est. Current Year |
-1.350 |
Return on Assets (ttm) |
-47.8 |
Shares Float (M) |
19.38 |
|
EPS Est. Next Year |
-1.050 |
PEG Ratio |
0.00 |
% Held by Insiders |
13.82 |
|
EPS Est. Next Quarter |
-0.250 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
53.15 |
|
Forward EPS |
-0.640 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
143 |
|
Book Value (p.s.) |
0.210 |
EBITDA (p.s.) |
-0.563 |
P/E |
-5.05 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
19.05 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-19.35 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-9.21 |
P/CF |
-9.24 |
|
|
|
|
|
|
